Nutrinia

About:

Nutrinia is developing unique therapies for Intestinal failure patients.

Website: http://www.nutrinia.com

Top Investors: OrbiMed, Pontifax, TPG Biotech, WuXi Healthcare Ventures, H.I.G. BioHealth Partners

Description:

Nutrinia is a neonatology company developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. Our current products in development are oral formulations of insulin shown to enhance adaptation and rehabilitation of the gut in infants. We at Nutrinia live by the belief that science is best used to make life better for people, especially the most vulnerable populations.

Total Funding Amount:

$43M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Ramat Gan, Tel Aviv, Israel

Founded Date:

2003-01-01

Contact Email:

info(AT)nutrinia.com

Founders:

Naim Shehadeh

Number of Employees:

11-50

Last Funding Date:

2016-08-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai